SCHEMBL522899

SCHEMBL522899

CC(C)(C)OC(=O)c1c(F)c(F)c(C(=O)O)c(F)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM6 O15303 1/20 0.36
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
ESR1 P03372 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GLRA3 O75311 1/20 0.31
GLRB P48167 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
CA14 Q9ULX7 1/20 0.31
GABRA1 P14867 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL522898 0.91 TSHR (0.37) GRM6TSHRMAPK1ESR1CYP2C9
SCHEMBL29159153 0.89 TSHR (0.36) GRM6TSHRMAPK1ESR1CYP2C9
SCHEMBL8350885 0.85 GRM6 (0.33) GRM6CYP2C9CYP2C19NPSR1GABRA1
SCHEMBL6580237 0.82 GRM6 (0.40) GRM6TSHRCYP2C9CYP2C19NPSR1
SCHEMBL28696145 0.80 SMN1; SMN2 (0.41) GRM6TSHRMAPK1ESR1CYP2C9
SCHEMBL5837200 0.78 GRM6 (0.33) GRM6CYP2C9CYP2C19NPSR1CA12
SCHEMBL27534695 0.77 GRM6 (0.37) GRM6TSHRCYP2C9CYP2C19NPSR1
SCHEMBL679953 0.76 CA1 (0.41) GRM6CYP2C9CYP2C19NPSR1CA12
SCHEMBL27511609 0.76 TSHR (0.53) TSHRMAPK1ESR1CYP2C9NPSR1
SCHEMBL522356 0.75 GRM6 (0.36) GRM6CYP2C9CYP2C19NPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110117217-B Preparation method of 1-bromomethyl-2, 3,5, 6-tetrafluoro-4- (trifluoromethyl) benzene 浙江普洛家园药业有限公司 2021-09-28 CN disclosed
EP-2415741-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND Sumitomo Chemical Company, Limited (JP) 2012-02-08 EP disclosed
US-20120029195-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-02-02 US disclosed
US-20120010417-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010417-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND ADH1A, ADH1C, ADH5 GRM6 817/4885TSHR 2221/4885MAPK1 3196/4885
US-20120029195-A1 METHOD FOR PRODUCING ALCOHOL COMPOUND AND CATALYST THEREFOR ADH1A, ADH1C, ADH5 GRM6 2369/4885TSHR 2411/4885MAPK1 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.